Quantitative Ultra-short Time-to-Echo Contrast-Enhanced Magnetic Resonance Imaging (qUTE-CE MRI) technique use Ferumoxytol as a Positive-Contrast Agent to Delineate Nanoparticle Accumulation in Tumors
Ju Qiao1, Codi Gharagouzloo2,3, Liam Timms4,5, Paraveen Kulkarni6, Craig Ferris6, Srinivas Sridhar4,5, and Anne L van de Ven4,5
1Mechanical and Industrial Engineering, Northeastern University, BOSTON, MA, United States, 2Radiology, Massachusetts General Hospital, 3Radiology, Harvard Medical School, 4Physics, Northeastern University, Boston, MA, United States, 5Nanomedicine Science & Technology Center, Northeastern University, Boston, MA, United States, 6Psychology, Northeastern University, Boston, MA, United States
Here we demonstrate quantitative
magnetic resonance imaging (qUTE-CE
MRI) technique, which employs FDA-approved ferumoxytol as a positive-contrast
agent to delineate nanoparticle accumulation in tumors.
This abstract and the presentation materials are available to members only;
a login is required.